James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 17,629 shares at $1.36 ($24K) on 2019-07-01, disclosed to the SEC on 2019-07-02.
Open-market purchase of $24k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.36 | 800 | $1K | 4.5% |
| 2 | $1.36 | 400 | $544 | 2.3% |
| 3 | $1.36 | 371 | $505 | 2.1% |
| 4 | $1.36 | 400 | $545 | 2.3% |
| 5 | $1.36 | 800 | $1K | 4.5% |
| 6 | $1.36 | 2,200 |
| $3K |
| 12.5% |
| 7 | $1.37 | 295 | $404 | 1.7% |
| 8 | $1.37 | 100 | $137 | 0.6% |
| 9 | $1.37 | 28 | $38 | 0.2% |
| 10 | $1.37 | 4,806 | $7K | 27.3% |
| 11 | $1.37 | 295 | $404 | 1.7% |
| 12 | $1.37 | 100 | $137 | 0.6% |
| 13 | $1.37 | 28 | $38 | 0.2% |
| 14 | $1.37 | 2,200 | $3K | 12.5% |
| 15 | $1.37 | 4,806 | $7K | 27.3% |
| Total | $1.37 avg | 17,629 | $24K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |